Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05979922 · ClinicalTrials.gov registry record · Phase 2
Mindfulness-based Cognitive Coping for ADRD Caregivers
A Phase 2 study, sponsored by Photozig.
- Completed
- Registry status
- Phase 2
- Development phase
- 174
- Enrollment target
NCT05979922 is a Phase 2 study that has completed, run by Photozig. The registered enrollment target is 174 participants.
The verdict
NCT05979922, a Phase 2 study, has completed, sponsored by Photozig.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 174 participants
- Enrollment target
Study Summary
This project will evaluate the effectiveness of the Mindfulness-based Cognitive Coping (MCC) intervention to alleviate stress and depressive symptoms of caregivers of Individuals with Alzheimer's Disease and Related Dementia.
Interventions
- BEHAVIORAL Traditional Educational/Resources Program
- BEHAVIORAL Mindfulness-based Cognitive Coping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2023-07-27 |
| Est. Completion | 2024-06-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05979922
The ClinicalTrials.gov registry entry for NCT05979922 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Photozig, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Traditional Educational/Resources Program is the first listed.
NCT05979922 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05979922 about?
NCT05979922 is a clinical study titled "Mindfulness-based Cognitive Coping for ADRD Caregivers". This project will evaluate the effectiveness of the Mindfulness-based Cognitive Coping (MCC) intervention to alleviate stress and depressive symptoms of caregivers of Individuals with Alzheimer's Disease and Related Dementia.
What is the current status of trial NCT05979922?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 174 participants. The study started on 2023-07-27. Estimated completion is 2024-06-17.
What interventions are being tested in trial NCT05979922?
The interventions under investigation include: Traditional Educational/Resources Program (BEHAVIORAL), Mindfulness-based Cognitive Coping (BEHAVIORAL).
Who is sponsoring clinical trial NCT05979922?
This trial is sponsored by Photozig, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.